- Global Pharma News & Resources

Orthobiologics Market to Reach $6.87 Billion at 4.3% CAGR Globally, by 2021 to 2025

Pune, Maharashtra, India, February 5 2021 (Wiredrelease) Allied Analytics –:Orthobiologics Market by Product (Demineralized Bone Matrix {DBM}, Allograft, Bone Morphogenetic Protein {BPM}, Viscosupplementation Products, Synthetic Bone Substitutes and Others), Application (Osteoarthritis & Degenerative Arthritis, Spinal Fusion, Fracture recovery, Soft Tissue Injuries, and Maxillofacial & Dental Applications), Type (Knee, Ankle, Hip, Wrist & Shoulder, Spine, and Others), and End User (Hospitals & Ambulatory Centers, Research & Academic Institute, and Dental Clinics): Global Opportunity Analysis and Industry Forecast, 2018–2025. The research offers a detailed analysis on changing market dynamics, key investment pockets, major segments, and market competition. According to the report, the global orthobiologics market generated $4.87 billion in 2017 and is projected to reach $6.87 billion by 2025, registering a CAGR of 4.3% from 2018 to 2025.

Surge in global geriatric population, which is prone to various diseases such as osteoarthritis and others, increase in awareness of orthobiologics, rise in demand for advanced treatment, surge in obesity, and rise in number of sports and road accidents are other factors that drive the growth of the global orthobiologics market. However, higher cost of orthobiologics and stringent approval process restrain the growth of the market. Conversely, high growth potential in developing nations and upsurge in demand for advanced treatment create new opportunities for the market growth.

Request Sample Report at:

Hospitals & ambulatory centers segment to be lucrative through 2025:-

Among end users, the hospitals & ambulatory centers segment was the largest in 2017, capturing 90% of the market share and would maintain its dominance through 2025. The same segment would grow at the fastest CAGR of 4.4% from 2018 to 2025. This is because these facilities are fully equipped for performing the surgeries and have the skilled professionals to carry out the procedures.

Viscosupplementation products segment to be lucrative through 2025:-

Among products, the viscosupplementation products segment accounted for half of the overall market share in 2017 and would retain its dominance through 2025. The same would grow at the fastest CAGR of 4.8% during the forecast period. This is due to the increase in geriatric population, rise in prevalence of osteoarthritis, and growth in lifestyle-induced disorders, such as obesity.

North America to be dominant, Asia-Pacific to exhibit the fastest growth through 2025:-

North America captured half of the market share in 2017 and is likely to dominate the market through 2025. This is due to rise in the elderly population, favorable reimbursement rates, rise in the prevalence of orthopedic disorders even among younger population, and increase in number of road accidents in the region. However, Asia-Pacific is expected to register the fastest CAGR of 5.7% from 2018 to 2025.

For Purchase Enquiry:

Key players of the industry:-

Leading market players analyzed in the research include Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group, Inc., Integra LifeSciences Holdings Corporation, Arthrex, Inc. (Arthrex), Johnson and Johnson (J&J), Exactec Inc., Medline Industries, Inc., Globus Medical, Inc., and NuVasive Inc. These market players have adopted various strategies including collaborations, joint ventures, partnerships, expansions, and others to gain a strong position in the industry.

Similar Reports:

Covid-19 Diagnostics Market – Global Opportunity Analysis and Industry Forecast, 2020–2022

Surgical Retractor Market – Global Opportunity Analysis and Industry Forecast, 2019–2026

In Vitro Toxicity Testing Market – Global Opportunity Analysis and Industry Forecast, 2020-2027

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.


David Correa

Portland, OR, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975


Follow Us on LinkedIn:

This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 05-Feb-2021